| 000 | 01166 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514160500.0 | ||
| 264 | 0 | _c20040116 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a1568-010X | ||
| 024 | 7 |
_a10.2174/1568010033344453 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGangur, Venu | |
| 245 | 0 | 0 |
_aCCR3 and CXCR3 as drug targets for allergy: principles and potential. _h[electronic resource] |
| 260 |
_bCurrent drug targets. Inflammation and allergy _cMar 2003 |
||
| 300 |
_a53-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aChemokines _xmetabolism |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity _xdrug therapy |
| 650 | 0 | 4 | _aReceptors, CCR3 |
| 650 | 0 | 4 | _aReceptors, CXCR3 |
| 650 | 0 | 4 |
_aReceptors, Chemokine _xagonists |
| 700 | 1 | _aBirmingham, Neil P | |
| 700 | 1 | _aThanesvorakul, Sirinart | |
| 700 | 1 | _aJoseph, Shama | |
| 773 | 0 |
_tCurrent drug targets. Inflammation and allergy _gvol. 2 _gno. 1 _gp. 53-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568010033344453 _zAvailable from publisher's website |
| 999 |
_c14304090 _d14304090 |
||